Prehospital Transdermal Glyceryl Trinitrate Treatment in Patients With Presumed Acute Stroke
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial
Lancet Neurol 2022 Nov 01;21(11)971-981, SA van den Berg, SM Uniken Venema, H Reinink, J Hofmeijer, WJ Schonewille, I Miedema, PSS Fransen, DM O Pruissen, TWM Raaijmakers, GW van Dijk, FE de Leeuw, JA van Vliet, VIH Kwa, H Kerkhoff, A van 't Net, R Boomars, A Siegers, T Lok, K Caminada, LM Esteve Cuevas, MC Visser, CP Zwetsloot, JMF Boomsma, MH Schipper, RPJ van Eijkelenburg, OA Berkhemer, D Nieboer, HF Lingsma, BJ Emmer, RJ van Oostenbrugge, A van der Lugt, YBWEM Roos, CBLM Majoie, DWJ Dippel, PJ Nederkoorn, HB van der WorpFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.